Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study

Heart

Volumn 98, Issue 8, 2012, Pages 650-655

  Rachas, Antoine ^a   Raffaitin, Christelle ^b   Barberger Gateau, Pascale ^b   Helmer, Catherine ^b   Ritchie, Karen ^c   Tzourio, Christophe ^d   Amouyel, Philippe ^e   Ducimetière, Pierre ^f   Empana, Jean Philippe ^a  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b INSERM   (France)

^c INSERM U1061   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; AGED; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERGLYCEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SEX DIFFERENCE;

ADIPOSITY; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; HYPERGLYCEMIA; MALE; METABOLIC SYNDROME X; RISK ASSESSMENT; SEX FACTORS;

EID: 84860143561     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301185     Document Type: Article

References (27)

1. Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non diabetic European men and women. Arch Intern Med 2004;164:1066-76. (Pubitemid 38668985)
2. Ford ES, Schulze MB, Pischon T, et al. Metabolic syndrome and risk of incident diabetes: findings from the European prospective Investigation into Cancer and Nutrition-Potsdam study. Cardiovasc Diabetol 2008;7:35.
3. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-14. (Pubitemid 46135879)
4. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-32.
5. Empana JP, Zureik M, Gariepy J, et al. The metabolic syndrome and the carotid artery structure in non institutionalized elderly subjects: the three-city study. Stroke 2007;38:893-9. (Pubitemid 46568449)
6. Butler J, Rodondi N, Zhu Y, et al. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006;47:1595-602.
7. McNeill AM, Katz R, Girman CJ, et al. Metabolic syndrome and cardiovascular disease in older people: the cardiovascular health study. J Am Geriatr Soc 2006;54:1317-24. (Pubitemid 44342879)
8. Lempiäinen P, Mykkänen L, Pyörälä K, et al. Insulin resistance syndrome predicts coronary heart disease events in elderly non diabetic men. Circulation 1999;100:123-8. (Pubitemid 29330009)
9. Lawlor DA, Smith GD, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 2006;49:41-8. (Pubitemid 43151612)
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third report of the National cholesterol Education Program (NCEP) expert Panel on Detection, Evaluation, and treatment of High blood cholesterol in adults (Adult treatment Panel III). JAMA 2001;285:2486-97.
11. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart Association/National heart, Lung, and blood Institute Scientific statement. Circulation 2005;112:2735-52. (Pubitemid 41532612)
12. Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-62. (Pubitemid 41338752)
13. Alberti KG, Eckel RH, Grundy SM, et al; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Force on Epidemiology and Prevention; National heart, Lung, and blood Institute; American heart association; World heart Federation; International Atherosclerosis Society; and International association for the study of obesity. Circulation 2009;120:1640-5.
14. The 3C Study Group. Vascular factors and risk of dementia: design of the Three- City Study and baseline characteristics of the study population. Neuroepidemiology 2003;22:316-25.
15. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72. (Pubitemid 351193639)
16. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004;23:2109-23. (Pubitemid 38968032)
17. Empana JP, Duciemetiere P, Balkau B, et al. Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I. Eur Heart J 2007;28:1149-54. (Pubitemid 47343879)
18. Hsia J, Bittner V, Tripputi M, et al. Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial. Am Heart J 2003;146:439-45. (Pubitemid 37083076)
19. Hoffmann R, Stellbrink E, Schröder J, et al. Impact metabolic syndrome angiographic clinical events after coronary intervention using bare-metal or sirolimuseluting stents. Am J Cardiol 2007;100:1347-52. (Pubitemid 47576009)
20. Lee WL, Cheung AM, Cape D, et al. Impact of diabetes on coronary artery disease in women and men: a metaanalysis of prospective studies. Diabetes Care 2000;23:962-8. (Pubitemid 30480024)
21. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet 2004;364:937-52. (Pubitemid 39208455)
22. Raffaitin C, Gin H, Empana JP, et al. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care 2009;32:169-74.
23. Kahn R, Buse J, Ferrannini E, et al American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American diabetes association and the European association for the study of diabetes. Diabetes Care 2005;28:2289-304. (Pubitemid 41242486)
24. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11- year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28:385-90. (Pubitemid 40170944)
25. Grundy SM. Metab syndrome a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007;92:399-404.
26. Sundström J, Risérus U, Byberg L, et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 2006;332:878-82.
27. Scuteri A, Najjar SS, Morrell CH, et al Cardiovascular Health Study. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005;28:882-7. (Pubitemid 40434490)